Predominance of Dense Low-Density Lipoprotein Particles Predicts Angiographic Benefit of Therapy in the Stanford Coronary Risk Intervention Project
Authors:
- 1 November 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 94 (9) , 2146-2153
Abstract
Background LDL particles differ in size and density. Individuals with LDL profiles that peak in relatively small, dense particles have been reported to be at increased risk of coronary artery disease. We hypothesized that response to coronary disease therapy in such individuals might differ from response in individuals whose profiles peak in larger, more buoyant LDL. We examined this hypothesis in the Stanford Coronary Risk Intervention Project, an angiographic trial that compared multifactorial risk-reduction intervention with the usual care of physicians. Methods and Results For 213 men, a bimodal frequency distribution of peak LDL density (g/mL) determined by analytical ultracentrifugation was used to classify baseline LDL profiles as “buoyant mode” (density ≤1.0378) or “dense mode” (density >1.0378). Coronary disease progression after 4 years was assessed by rates of change (mm/y, negative when arteries narrow) of minimum artery diameter. Rates for buoyant-mode subjects were −0.038±0.007 (mean±SEM) in usual care (n=65) and −0.039±0.010 in intervention (n=56; P =.6). Rates for dense-mode subjects were −0.054±0.012 in usual care (n=51) and −0.008±0.009 in intervention (n=41, P =.007). Lipid changes did not account for this difference in angiographic response. Conclusions Different types of LDL profile may predict different responses to specific therapies, perhaps because metabolic processes determine both LDL profiles and responses to therapies.Keywords
This publication has 19 references indexed in Scilit:
- Effects of the lipid intervention in the Stanford Coronary Risk Intervention Project1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Heterogeneity of plasma low-density lipoproteins and atherosclerosis riskCurrent Opinion in Lipidology, 1994
- Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease riskAtherosclerosis, 1994
- Benefits of lipid-lowering therapy in men with elevated apolipoprotein B are not confined to those with very high low density lipoprotein cholesterolJACC, 1994
- Detection and quantitation of LDL subfractionsCurrent Opinion in Lipidology, 1992
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Can lifestyle changes reverse coronary heart disease?The Lancet, 1990
- Angiographic progression of coronary artery disease and the development of myocardial infarctionJACC, 1988
- Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987